Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yuko Matsuki-Muramoto, Kazuhisa Nozawa, Kaori Uomori, Iwao Sekigawa & Yoshinari Takasaki. (2017) Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin–angiotensin systems. Modern Rheumatology 27:1, pages 77-86.
Read now
Read now
Y You, W Zhao, S Chen, W Tan, Y Dan, F Hao & G Deng. (2010) Association of TBX21 gene haplotypes in a Chinese population with systemic lupus erythematosus. Scandinavian Journal of Rheumatology 39:3, pages 254-258.
Read now
Read now
H. M. Habib, T. E. Taher, D. A. Isenberg & R. A. Mageed. (2009) Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha. Scandinavian Journal of Rheumatology 38:2, pages 112-120.
Read now
Read now
Chang-Hee Suh & Hyoun-Ah Kim. (2008) Cytokines and their receptors as biomarkers of systemic lupus erythematosus. Expert Review of Molecular Diagnostics 8:2, pages 189-198.
Read now
Read now
Articles from other publishers (33)
Stefan Rosenberger, Reinmar Undeutsch, Reza Akbarzadeh, Justus Ohmes, Philipp Enghard, Gabriela Riemekasten & Jens Y. Humrich. (2023) Regulatory T cells inhibit autoantigen-specific CD4+ T cell responses in lupus-prone NZB/W F1 mice. Frontiers in Immunology 14.
Crossref
Crossref
Yoshiyuki Akiyama, Kaori Harada, Jimpei Miyakawa, Karl J. Kreder, Michael A. O’Donnell, Maeda Daichi, Hiroto Katoh, Miyuki Hori, Kensuke Owari, Kazunobu Futami, Shumpei Ishikawa, Tetsuo Ushiku, Haruki Kume, Yukio Homma & Yi Luo. (2023) Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis. iScience 26:11, pages 108262.
Crossref
Crossref
Yun-Wen Chen, Po-Ke Hsu, Shih-Ping Lin & Hsin-Hua Chen. (2023) Appendicitis is associated with an increased risk of systemic lupus erythematosus: a nationwide, population-based, case–control study. Clinical Rheumatology 42:7, pages 1783-1791.
Crossref
Crossref
Surjyapratap Sarangi, Suraj K Nahak, Sunali Padhi, Bidyutprabha Pradhan, Nisha Nayak, Abhijit Pati & Aditya K Panda. (2022) Interferon-gamma (IFN-γ) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: Observation from a meta-analysis. Lupus 32:2, pages 284-294.
Crossref
Crossref
Fabrizio De Benedetti, Giusi Prencipe, Claudia Bracaglia, Emiliano Marasco & Alexei A. Grom. (2021) Targeting interferon-γ in hyperinflammation: opportunities and challenges. Nature Reviews Rheumatology 17:11, pages 678-691.
Crossref
Crossref
Shereen Oon. 2021. Pathogenesis of Systemic Lupus Erythematosus. Pathogenesis of Systemic Lupus Erythematosus
67
95
.
Stefanie Gryzik, Yen Hoang, Timo Lischke, Elodie Mohr, Melanie Venzke, Isabelle Kadner, Josephine Poetzsch, Detlef Groth, Andreas Radbruch, Andreas Hutloff & Ria Baumgrass. (2020) Identification of a super-functional Tfh-like subpopulation in murine lupus by pattern perception. eLife 9.
Crossref
Crossref
Gabriela Tejon, Yessia Hidalgo, Maria Rosa Bono & Mario Rosemblatt. 2020. Lupus - New Advances and Challenges. Lupus - New Advances and Challenges.
Erin A. Yamamoto, Jane K. Nguyen, Jessica Liu, Emma Keller, Nicole Campbell, Cun-Jin Zhang, Howard R. Smith, Xiaoxia Li & Trine N Jørgensen. (2020) Low Levels of Vitamin D Promote Memory B Cells in Lupus. Nutrients 12:2, pages 291.
Crossref
Crossref
Fatemeh Mardani, Mahmoud Mahmoudi, Seyed‐Alireza Esmaeili, Sahar Khorasani, Nafiseh Tabasi & Maryam Rastin. (2018)
In vivo study: Th1–Th17 reduction in pristane‐induced systemic lupus erythematosus mice after treatment with tolerogenic
Lactobacillus
probiotics
. Journal of Cellular Physiology 234:1, pages 642-649.
Crossref
Crossref
Fok-Moon Lum, David C B Lye, Jeslin J L Tan, Bernett Lee, Po-Ying Chia, Tze-Kwang Chua, Siti N Amrun, Yiu-Wing Kam, Wearn-Xin Yee, Wei-Ping Ling, Vanessa W X Lim, Vincent J X Pang, Linda K Lee, Esther W H Mok, Chia-Yin Chong, Yee-Sin Leo & Lisa F P Ng. (2018) Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus–Infected Patients. The Journal of Infectious Diseases 218:5, pages 814-824.
Crossref
Crossref
Visnja Kokic, Dusanka Martinovic Kaliterna, Mislav Radic, Leida Tandara & Dijana Perkovic. (2017) Association between vitamin D, oestradiol and interferon-gamma in female patients with inactive systemic lupus erythematosus: A cross-sectional study. Journal of International Medical Research 46:3, pages 1162-1171.
Crossref
Crossref
Sung Soo Ahn, Eun Seong Park, Joo Sung Shim, Sang-Jun Ha, Beom Seok Kim, Seung Min Jung, Sang-Won Lee, Yong-Beom Park & Jason Jungsik Song. (2017) Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Jessica A. Muhlenbeck, Daniel E. Butz, Jake M. Olson, Daniela Uribe-Cano & Mark E. Cook. (2017) Dietary Conjugated Linoleic Acid-c9t11 Prevents Collagen-Induced Arthritis, Whereas Conjugated Linoleic Acid-t10c12 Increases Arthritic Severity. Lipids 52:4, pages 303-314.
Crossref
Crossref
V Kokic, D Martinovic Kaliterna, M Radic, D Perkovic, M Cvek & V Capkun. (2015)
Relationship between vitamin D, IFN-γ, and E
2
levels in systemic lupus erythematosus
. Lupus 25:3, pages 282-288.
Crossref
Crossref
Amanda J. Steiman, Dafna D. Gladman, Dominique Ibañez, Babak Noamani, Carolina Landolt-Marticorena, Murray B. Urowitz & Joan E. Wither. (2015) Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. The Journal of Rheumatology 42:12, pages 2318-2326.
Crossref
Crossref
Manfred Relle, Julia Weinmann-Menke, Eva Scorletti, Lorenzo Cavagna & Andreas Schwarting. (2015) Genetics and novel aspects of therapies in systemic lupus erythematosus. Autoimmunity Reviews 14:11, pages 1005-1018.
Crossref
Crossref
Timothy A. Gottschalk, Evelyn Tsantikos & Margaret L. Hibbs. (2015) Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus. Frontiers in Immunology 6.
Crossref
Crossref
Christian M. Hedrich, Thomas Rauen, Sokratis A. ApostolidisAlexandros P. GrammatikosNoe Rodriguez RodriguezChristina IoannidisVasileios C. KyttarisJose C. CrispinGeorge C. Tsokos. (2014)
Stat3 promotes IL-10 expression in lupus T cells through
trans-
activation and chromatin remodeling
. Proceedings of the National Academy of Sciences 111:37, pages 13457-13462.
Crossref
Crossref
Enass A. Elewa, Omyma Zakaria, Enas I. Mohamed & Ghada Boghdadi. (2014) The role of interleukins 4, 17 and interferon gamma as biomarkers in patients with Systemic Lupus Erythematosus and their correlation with disease activity. The Egyptian Rheumatologist 36:1, pages 21-27.
Crossref
Crossref
S.-W. Lee, Y.-B. Park, J. Yang, K.-H. Park, S.-K. Lee, K. H. Choi & B. S. Kim. (2012) Attenuation of nephritis in lupus-prone mice by thalidomide. Rheumatology 51:12, pages 2131-2140.
Crossref
Crossref
G.-S. Ling, H. T. Cook, M. Botto, Y.-L. Lau & F.-P. Huang. (2011) An essential protective role of IL-10 in the immunological mechanism underlying resistance vs susceptibility to lupus induction by dendritic cells and dying cells. Rheumatology 50:10, pages 1773-1784.
Crossref
Crossref
Christopher M Reilly, Nicole Regna & Nilamadhab Mishra. (2011) HDAC Inhibition in Lupus Models. Molecular Medicine 17:5-6, pages 417-425.
Crossref
Crossref
Y LiuT Zhu, G CaiY QinW WangG TangD Zhao & Q Shen. (2011)
Elevated circulating CD4
+
ICOS
+
Foxp3
+
T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus
. Lupus 20:6, pages 620-627.
Crossref
Crossref
Kim Ohl & Klaus Tenbrock. (2011) Inflammatory Cytokines in Systemic Lupus Erythematosus. Journal of Biomedicine and Biotechnology 2011, pages 1-14.
Crossref
Crossref
Jia XIA & Xiao SU. (2010) Interferon-gamma and systemic lupus erythematosus. Academic Journal of Second Military Medical University 30:9, pages 1020-1022.
Crossref
Crossref
Shimpei Kasagi, Seiji Kawano, Taku Okazaki, Tasuku Honjo, Akio Morinobu, Saori Hatachi, Kenichiro Shimatani, Yoshimasa Tanaka, Nagahiro Minato & Shunichi Kumagai. (2010) Anti-Programmed Cell Death 1 Antibody Reduces CD4+PD-1+ T Cells and Relieves the Lupus-Like Nephritis of NZB/W F1 Mice. The Journal of Immunology 184:5, pages 2337-2347.
Crossref
Crossref
Yan ZhangHa-Jeong KimSoichiro YamamotoXiaoyan KangXiaojing Ma. (2010) Regulation of Interleukin-10 Gene Expression in Macrophages Engulfing Apoptotic Cells. Journal of Interferon & Cytokine Research 30:3, pages 113-122.
Crossref
Crossref
R. Rizzo, T. V. F. Hviid, M. Govoni, M. Padovan, M. Rubini, L. Melchiorri, M. Stignani, S. Carturan, M. T. Grappa, M. Fotinidi, S. Ferretti, A. Voss, H. Laustrup, P. Junker, F. Trotta & O. R. Baricordi. (2008) HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71:6, pages 520-529.
Crossref
Crossref
Robin A. Herlands, Jacqueline William, Uri Hershberg & Mark J. Shlomchik. (2007) Anti-chromatin antibodies drivein vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. European Journal of Immunology 37:12, pages 3339-3351.
Crossref
Crossref
E Y Chung, J Liu, Y Zhang & X Ma. (2007) Differential expression in lupus-associated IL-10 promoter single-nucleotide polymorphisms is mediated by poly(ADP-ribose) polymerase-1. Genes & Immunity 8:7, pages 577-589.
Crossref
Crossref
G. Kökény, M. Godó, E. Nagy, M. Kardos, K. Kotsch, P. Casalis, C. Bodor, L. Rosivall, H-D. Volk, A.C. Zenclussen & P. Hamar. (2016) Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. Lupus 16:7, pages 465-477.
Crossref
Crossref
Chun Xie, Xiangmei Qin, Geetha Jonnala, Yimei Gong, Mei Yan, Peijun Zong, Xin J. Zhou & Chandra Mohan. (2007) Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression. Clinical Immunology 124:1, pages 49-56.
Crossref
Crossref